This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Asthma
and you are
between 15 and 85
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will investigate the additive effect of montelukast (MK0476) taken along with inhaled beclomethasone versus inhaled beclomethasone alone.

Provided treatments

  • Drug: montelukast sodium
  • Drug: beclomethasone
  • Drug: Placebo inhaler
  • Drug: placebo tablet
Tris trial is registered with FDA with number: NCT00911547. The sponsor of the trial is Merck Sharp & Dohme Corp. and it is looking for 642 volunteers for the current phase.
Official trial title:
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 2-Period, Parallel-Group Study to Assess the Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients